Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Journal Article (Journal Article)

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

Full Text

Duke Authors

Cited Authors

  • Coit, DG; Thompson, JA; Albertini, MR; Barker, C; Carson, WE; Contreras, C; Daniels, GA; DiMaio, D; Fields, RC; Fleming, MD; Freeman, M; Galan, A; Gastman, B; Guild, V; Johnson, D; Joseph, RW; Lange, JR; Nath, S; Olszanski, AJ; Ott, P; Gupta, AP; Ross, MI; Salama, AK; Skitzki, J; Sosman, J; Swetter, SM; Tanabe, KK; Wuthrick, E; McMillian, NR; Engh, AM

Published Date

  • April 1, 2019

Published In

Volume / Issue

  • 17 / 4

Start / End Page

  • 367 - 402

PubMed ID

  • 30959471

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0018


  • eng

Conference Location

  • United States